Grantham, Mayo, Van Otterloo & Co (GMO)’s Timken Company TKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.95M Sell
13,426
-4,961
-27% -$597K ﹤0.01% 443
2026
Q1
$1.85M Buy
18,387
+925
+5% +$91.9K ﹤0.01% 436
2025
Q4
$1.47M Sell
17,462
-23
-0.1% -$1.83K ﹤0.01% 440
2025
Q3
$1.31M Sell
17,485
-11
-0.1% -$848 ﹤0.01% 423
2025
Q2
$1.27M Sell
17,496
-1,711
-9% -$116K ﹤0.01% 420
2025
Q1
$1.38M Buy
+19,207
New +$1.48M ﹤0.01% 403
2024
Q1
Sell
-37,988
Closed -$3.04M 551
2023
Q4
$3.04M Buy
37,988
+12,154
+47% +$894K 0.01% 327
2023
Q3
$1.9M Sell
25,834
-27,143
-51% -$2.2M 0.01% 409
2023
Q2
$4.85M Buy
52,977
+24,377
+85% +$1.92M 0.02% 335
2023
Q1
$2.34M Buy
28,600
+6,500
+29% +$526K 0.01% 405
2022
Q4
$1.56M Buy
22,100
+18,100
+453% +$1.26M 0.01% 463
2022
Q3
$236K Buy
+4,000
New +$248K ﹤0.01% 661
2022
Q1
Sell
-5,032
Closed -$349K 763
2021
Q4
$349K Sell
5,032
-107
-2% -$7.5K ﹤0.01% 637
2021
Q3
$336K Sell
5,139
-4,718
-48% -$351K ﹤0.01% 631
2021
Q2
$794K Sell
9,857
-6,100
-38% -$516K ﹤0.01% 566
2021
Q1
$1.29M Buy
15,957
+5,300
+50% +$423K 0.01% 546
2020
Q4
$824K Sell
10,657
-41,600
-80% -$2.83M 0.01% 599
2020
Q3
$2.83M Sell
52,257
-4,500
-8% -$232K 0.02% 351
2020
Q2
$2.58M Sell
56,757
-91,000
-62% -$3.59M 0.02% 360
2020
Q1
$4.78M Sell
147,757
-170,527
-54% -$8.07M 0.04% 248
2019
Q4
$17.9M Sell
318,284
-73,995
-19% -$3.74M 0.12% 131
2019
Q3
$17.1M Sell
392,279
-167,300
-30% -$7.39M 0.12% 124
2019
Q2
$28.7M Sell
559,579
-85,100
-13% -$4.07M 0.2% 81
2019
Q1
$28.1M Buy
644,679
+549,700
+579% +$23.4M 0.2% 71
2018
Q4
$3.54M Buy
94,979
+20,200
+27% +$817K 0.03% 217
2018
Q3
$3.73M Buy
74,779
+1,500
+2% +$70.8K 0.03% 241
2018
Q2
$3.19M Buy
73,279
+51,679
+239% +$2.41M 0.02% 261
2018
Q1
$985K Buy
+21,600
New +$1.04M 0.01% 378

Other funds holding TKR

Grantham, Mayo, Van Otterloo & Co (GMO)'s TKR Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) reduced its Timken Company (TKR) stake by 27% in Q2 2026, selling an estimated $597K and leaving 13,426 shares worth $1.95M. The position accounts for ﹤0.01% of the portfolio, ranked #443.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in TKR in Q1 2018 and has held it in 28 quarters since. The position peaked at $28.7M in Q2 2019. 600 funds tracked by Wall St. Rank hold TKR as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 13,426 shares of Timken Company worth $1.95M as of Q2 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 4,961 Timken Company shares in Q2 2026, an estimated $597K.
  • Timken Company made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #443 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Timken Company in Q1 2018 and has held it in 28 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Timken Company position peaked at $28.7M in Q2 2019.
  • 600 funds tracked by Wall St. Rank held Timken Company as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.